The US company Barr Pharmaceuticals is set to acquire a 72.67% stake in the leading Croatian pharmaceutical producer, Pliva, having deposited more than 13.5m Pliva shares with the central depository agency in Zagreb on October 10th.
Američka kompanija Bar Farmaseutikals spremna je da preuzme 72,67 procenata deonica vodećeg hrvatskog farmaceutskog proizvođača Plive, nakon što je 10. oktobra deponovao deonice Plive u iznosu od preko 13,5 miliona u centralnu depozitarnu agenciju u Zagrebu.